Xenia’s Q3 results and raised full-year outlook were positive, but the stock rose a more measured 2.0% after earnings. Results benefited from broad-based RevPAR growth and margin expansion, while management expects RevPAR growth to outpace total RevPAR growth for the full year, partly because transient demand contributes less ancillary revenue than group business.
Shares dropped 5.7% following earnings as investors reacted negatively to margin compression and cautious near-term demand outlook, despite modest revenue growth and stable operating metrics. Key Takeaways: